Citation Tools

Download PDFPDF

Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic
Free

Download to a citation manager

Cite this article as:
McGoran J, Wilson A, McErlain S, et al
Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic